OP
OKYO Pharma Limited Stock: price and insider trades · United Kingdom
ISIN GG00BD3FV870GB·
OKYO Pharma Limited: what insiders have been doing
We have very little insider data for OKYO Pharma Limited so far: the most recent filing dates from 24 November 2022. With so few records, no pattern can be drawn yet. Source: insider filings from RNS (LSE). Past trades are no guide to future returns.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 24 November 2022
Declarations3 total
- 5,000,000 shares@ £0.0625100.0% of flowXLONISIN GG00BD3FV870FCA-NSM:4589503
- 8,650,000 shares@ £0.08100.0% of flowXLONISIN GG00BD3FV870FCA-NSM:4257645
- 13,500,000 shares@ £0.049100.0% of flowXLONISIN GG00BD3FV870FCA-NSM:4095348
3 of 3 declarations
About OKYO Pharma Limited
OKYO Pharma Limited is a biopharmaceutical company focused on developing treatments for ocular and inflammatory diseases. The company is listed on the London Stock Exchange (XLON).
